The long term objective of this proposal is to establish Protein Arginine Methyltransferases and Dimethyarginine Dimethylaminohydrolase (DDAH), the enzymes responsible for methylarginine synthesis and metabolism, as a key regulator of endothelial function. It is our hypothesis that the increased plasma ADMA observed in cardiovascular disease is a biomarker of DDAH activity and that many of the endothelial affects attributed to ADMA are directly manifested through altered DDAH-PRMT activity. We have shown that in addition to the direct effects of ADMA on eNOS activity, DDAH modulates endothelial NO production through ADMA independent mechanisms involving altered protein-methylation and amino acid metabolism. The goals of the current proposal are to: 1.) identify the pathways of ADMA metabolism in the endothelium;2.) determine the mechanisms through which DDAH modulates endothelial protein-arginine methylation and define the effects of protein methylation on endothelial function;3.) determine the mechanisms through which DDAH regulates endothelial L-arginine metabolism and the consequences on endothelial NO production;and 4.) identify the mechanisms through which the PRMT-DDAH-ADMA axis regulates endothelial function and atherosusceptibility. For each of these aims, a combination of cellular, molecular, biophysical and physiological approaches will be used to characterize the effects of DDAH on endothelial function using in vitro and in vivo models. Results from these studies will provide fundamental mechanistic information regarding the mechanisms through which the PRMT-DDAH-ADMA axis modulates cellular function and may lead to new approaches to treat vascular disease.

Public Health Relevance

This research is relevant to public health since atherosclerosis is among the leading cause morbidity and mortality in Americans. Our research has discovered new cellular pathways that are involved in the development of vascular diseases. Research supported by this grant may help identify new drugs to treat arterial pathology and could improve the quality of life of people suffering from cardiovascular disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL081734-08
Application #
8082624
Study Section
Atherosclerosis and Inflammation of the Cardiovascular System Study Section (AICS)
Program Officer
Mcdonald, Cheryl
Project Start
2005-07-01
Project End
2014-11-30
Budget Start
2011-12-01
Budget End
2012-11-30
Support Year
8
Fiscal Year
2012
Total Cost
$381,250
Indirect Cost
$131,250
Name
Ohio State University
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Li, Yuanjing; Cai, Ming; Sun, Qinghua et al. (2013) Hyperoxia and transforming growth factor ?1 signaling in the post-ischemic mouse heart. Life Sci 92:547-54
Zweier, Jay L; Chen, Chun-An; Druhan, Lawrence J (2011) S-glutathionylation reshapes our understanding of endothelial nitric oxide synthase uncoupling and nitric oxide/reactive oxygen species-mediated signaling. Antioxid Redox Signal 14:1769-75
Chen, Chun-An; Lin, Cho-Hao; Druhan, Lawrence J et al. (2011) Superoxide induces endothelial nitric-oxide synthase protein thiyl radical formation, a novel mechanism regulating eNOS function and coupling. J Biol Chem 286:29098-107
Karuppiah, Kanchana; Druhan, Lawrence J; Chen, Chun-an et al. (2011) Suppression of eNOS-derived superoxide by caveolin-1: a biopterin-dependent mechanism. Am J Physiol Heart Circ Physiol 301:H903-11
Pope, Arthur J; Karrupiah, Kanchana; Kearns, Patrick N et al. (2009) Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production. J Biol Chem 284:35338-47
Pope, Arthur J; Karuppiah, Kanchana; Cardounel, Arturo J (2009) Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production. Pharmacol Res 60:461-5
Druhan, Lawrence J; Forbes, Scott P; Pope, Arthur J et al. (2008) Regulation of eNOS-derived superoxide by endogenous methylarginines. Biochemistry 47:7256-63
Forbes, Scott P; Druhan, Lawrence J; Guzman, Jorge E et al. (2008) Mechanism of 4-HNE mediated inhibition of hDDAH-1: implications in no regulation. Biochemistry 47:1819-26
Pope, Arthur J; Druhan, Lawrence; Guzman, Jorge E et al. (2007) Role of DDAH-1 in lipid peroxidation product-mediated inhibition of endothelial NO generation. Am J Physiol Cell Physiol 293:C1679-86
Cardounel, Arturo J; Cui, Hongmei; Samouilov, Alexandre et al. (2007) Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function. J Biol Chem 282:879-87